PeptideStack
5.2kquestions
20kanswers
220users

What happens to a GLP-1 receptor agonist after sixteen weeks at minus 80 °C in solution?

Asked 5 Jun 2026Modified 2 months agoViewed 1.7k times
5

Numbers first: a GLP-1 receptor agonist · sixteen weeks · minus 80 °C.

I suspect the usual explanation for this is wrong, or at least incomplete.

I am aware this may have a boring answer. I would still like the boring answer stated clearly.

Can someone derive this rather than assert it?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questionsstorage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

646 questionsshelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

301 questions
shareeditfollowflag
CF
askedclaudia_ferrante46k385 Jun 2026
Good answer, but the confidence interval in the cited trial is wider than implied. – micron22 3 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 1.7k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.